Literature DB >> 27999997

Level I lymph node involvement in patients with N1b papillary thyroid carcinoma: a prospective study.

Ahmad M Eweida1,2, Mahmoud F Sakr3, Yasser Hamza3, Mohamed R Khalil3, Essam Gabr3, Tarek Koraitim3, Hatem F Al-Wagih3, Waleed Abo-Elwafa3, Tarek Ezzat Abdel-Aziz3,4, Ahmed A Diab3, Basma El-Sabaa5, Aman S Nabawi3.   

Abstract

Most of the studies on the incidence, pattern, and predictive factors of lymph node (LN) metastasis with papillary thyroid carcinoma (PTC) have been performed retrospectively and no common consensus has been reached regarding the predictors for the involvement of level I LNs. This study was conducted prospectively to determine the incidence and the possible predictors of level I involvement in N1b PTC patients. The study included 30 consecutive patients with N1b stage of PTC. All the patients underwent neck dissection (ND) including level I. The relation between involvement of level I LNs and various clinicopathological variables was studied. Unilateral neck dissection was performed in 24 patients and bilateral neck dissection in six patients leading to 36 NDs. Level I was excised in all patients, with five specimens (14%) positive for metastasis. Levels II, III, IV, V, VI, and VII were positive in 52.8, 58.3, 58.3, 33.3, 63, and 22.2%, respectively. Level I involvement was significantly related to the number of lymph node levels affected (p = 0.003) and macroscopic extranodal invasion (p = 0.04). It was not related to the involvement of other individual levels, gender, age, size of the largest thyroid nodule, size of the largest LN involved, or histo-pathological variant of the tumor. This study suggests that including level I in therapeutic neck dissection for N1b PTC patients might be recommended in selected cases of multiple level involvement and macroscopic extranodal invasion requiring sacrifice of internal jugular vein, spinal accessory nerve, or sternomastoid muscle.

Entities:  

Keywords:  Extranodal invasion; Level I; Lymph node metastases; Neck dissection; Papillary thyroid carcinoma

Mesh:

Year:  2016        PMID: 27999997     DOI: 10.1007/s00405-016-4423-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  37 in total

1.  Pattern and predictive factors of regional lymph node metastasis in papillary thyroid carcinoma: a prospective study.

Authors:  Inn Chul Nam; Jun Ook Park; Young Hoon Joo; Kwang Jae Cho; Min Sik Kim
Journal:  Head Neck       Date:  2012-01-20       Impact factor: 3.147

2.  Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.

Authors:  Bon Seok Koo; Eun Chang Choi; Yeo-Hoon Yoon; Dong-Hyun Kim; Eung-Hyub Kim; Young Chang Lim
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

Review 3.  Consensus statement on the classification and terminology of neck dissection.

Authors:  K Thomas Robbins; Ashok R Shaha; Jesus E Medina; Joseph A Califano; Gregory T Wolf; Alfio Ferlito; Peter M Som; Terry A Day
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-05

Review 4.  PET/CT in the management of thyroid cancers.

Authors:  Charles Marcus; Pat W Whitworth; Devaki S Surasi; Sara I Pai; Rathan M Subramaniam
Journal:  AJR Am J Roentgenol       Date:  2014-06       Impact factor: 3.959

5.  Candidates for limited lateral neck dissection among patients with metastatic papillary thyroid carcinoma.

Authors:  Byung Chul Kang; Jong-Lyel Roh; Jeong Hyun Lee; Kyung-Ja Cho; Gyungyub Gong; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

6.  Neck dissection for surgical treatment of lymphnode metastasis in papillary thyroid carcinoma.

Authors:  M Ducci; M Appetecchia; M Marzetti
Journal:  J Exp Clin Cancer Res       Date:  1997-09

7.  Neurological complications following functional neck dissection.

Authors:  M P Prim; J I De Diego; J M Verdaguer; N Sastre; I Rabanal
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-12-28       Impact factor: 2.503

8.  Skip metastases in thyroid cancer leaping the central lymph node compartment.

Authors:  Andreas Machens; Hans-Jürgen Holzhausen; Henning Dralle
Journal:  Arch Surg       Date:  2004-01

9.  Selective modified radical neck dissection for papillary thyroid cancer-is level I, II and V dissection always necessary?

Authors:  N R Caron; Y Y Tan; J B Ogilvie; F Triponez; E S Reiff; E Kebebew; Q Y Duh; O H Clark
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

10.  Should level V be included in lateral neck dissection in treating papillary thyroid carcinoma?

Authors:  Xiao-Jun Zhang; Dan Liu; De-Bin Xu; Ya-Qi Mu; Wen-Kuan Chen
Journal:  World J Surg Oncol       Date:  2013-11-25       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.